| Mrs Jennifer Anne Waller, APRN-CNP | |
|
1508 W 22nd St, Suite 101, Sioux Falls, SD 57105-1508 | |
| (605) 328-3840 | |
| Not Available |
| Full Name | Mrs Jennifer Anne Waller |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1508 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295271690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP001179 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Usd Medical Center | Sioux falls, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center | 8325950215 | 707 |
News Archive
New research from the University of Copenhagen has found that maintaining a good night's sleep is important for our future health, partly because of how it affects lifestyle factors. Previous population based studies have not provided sufficient information on the timing of changes in both sleep and lifestyle to tease out cause and effect relations of this highly intertwined relationship.
It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.
Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.
› Verified 3 days ago
| Entity Name | Sanford Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396764254 PECOS PAC ID: 0244143824 Enrollment ID: O20031110000532 |
News Archive
New research from the University of Copenhagen has found that maintaining a good night's sleep is important for our future health, partly because of how it affects lifestyle factors. Previous population based studies have not provided sufficient information on the timing of changes in both sleep and lifestyle to tease out cause and effect relations of this highly intertwined relationship.
It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.
Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.
› Verified 3 days ago
| Entity Name | Sanford Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
New research from the University of Copenhagen has found that maintaining a good night's sleep is important for our future health, partly because of how it affects lifestyle factors. Previous population based studies have not provided sufficient information on the timing of changes in both sleep and lifestyle to tease out cause and effect relations of this highly intertwined relationship.
It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.
Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Anne Waller, APRN-CNP 1508 W 22nd St, Suite 101, Sioux Falls, SD 57105-1508 Ph: (605) 328-3840 | Mrs Jennifer Anne Waller, APRN-CNP 1508 W 22nd St, Suite 101, Sioux Falls, SD 57105-1508 Ph: (605) 328-3840 |
News Archive
New research from the University of Copenhagen has found that maintaining a good night's sleep is important for our future health, partly because of how it affects lifestyle factors. Previous population based studies have not provided sufficient information on the timing of changes in both sleep and lifestyle to tease out cause and effect relations of this highly intertwined relationship.
It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.
Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.
› Verified 3 days ago
Paul Stamp, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave, Suite 610, Sioux Falls, SD 57105 Phone: 605-322-8860 | |
Lien Lieve Swieringa, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2601 S Ellis Rd, Sioux Falls, SD 57106 Phone: 605-312-3000 | |
Kaitlyn Sarah Isaacson, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6110 S Minnesota Ave, Sioux Falls, SD 57108 Phone: 605-328-5800 | |
Mariah Schurman, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 18th St, Sioux Falls, SD 57105 Phone: 605-312-2100 | |
Dillon Matthew Hansen, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave # 2, Sioux Falls, SD 57105 Phone: 605-322-7020 | |
Chelsey Zondervan, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1309 W 17th St, Sioux Falls, SD 57104 Phone: 605-328-8000 Fax: 605-328-8001 | |
Mrs. Donna Lynn Sebesta, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1900 S Grandview Ave, Sioux Falls, SD 57103 Phone: 605-371-3436 |